LARP1 and ovarian carcinoma: LARP1 knockdown in ovarian cancer derived cell lines (SKOV3 and OVCAR8, both highly resistant to platinum-based therapies), decreased cell viability while increasing apoptosis, and enhanced the sensitivity of cells to commonly used drugs for EOC treatment (CP, Paclitaxel and Gemcitabine).